142 filings
Page 2 of 8
8-K
7ea3fng7jqd 2c9gyd56
8 Nov 22
Mirati Therapeutics Reports Third Quarter 2022 Financial Results and Recent Corporate Updates
4:23pm
8-K
m6c3u2o3f6prlamfv1gl
8 Sep 22
Mirati Therapeutics Presents Late-Breaking Adagrasib Monotherapy and Combination Results in Advanced Colorectal Cancer
6:08am
8-K
gncyd2u4biumv z2f
3 Aug 22
Mirati Therapeutics Reports Second Quarter 2022 Financial Results and Recent Corporate Updates
4:04pm
8-K
gshov
7 Jun 22
Other Events
8:06am
8-K
fjq6qbfi
6 Jun 22
Presentation marks first clinical dataset with a KRASG12C-inhibitor in patients with active, untreated CNS metastases
8:07am
8-K
jd8u0v tnem2
26 May 22
Other Events
5:06pm
8-K
q7276dx8u2m4
16 May 22
Mirati Therapeutics Appoints Laurie Stelzer as Chief Financial Officer
4:42pm
8-K
uaz cs3idbq
12 May 22
Departure of Directors or Certain Officers
5:07pm
8-K
3thotjf1ifq
4 May 22
Mirati Therapeutics Reports First Quarter 2022 Financial Results and Recent Corporate Updates
4:10pm
8-K
k2v4hngikrk2177b
28 Feb 22
Mirati Therapeutics Reports Fourth Quarter and Full Year 2021 Financial Results and Recent Corporate Updates
4:06pm
8-K
ack3nkgkclnu9sx2wm
15 Feb 22
Other Events
4:16pm
8-K
7ugpja4og3o8vqdbl
10 Jan 22
Regulation FD Disclosure
10:55am
8-K
h5j3cj6lzugnbhv30vu
12 Nov 21
Mirati Therapeutics Announces Proposed Public Offering of Common Stock
6:16am
8-K
5tikflu8gtgllewkrt
9 Nov 21
Other Events
12:00am
8-K
j2p05v731h
8 Nov 21
Mirati Therapeutics Reports Third Quarter 2021 Financial Results and Recent Corporate Updates
4:08pm
8-K
3g3qzuve
1 Nov 21
Departure of Directors or Certain Officers
7:32am
8-K
8jtbde63
20 Sep 21
Mirati Therapeutics Appoints David Meek as Chief Executive Officer
8:10am
8-K
pw4g25j98p1td9zafy15
5 Aug 21
Mirati Therapeutics Reports Second Quarter 2021 Financial Results
4:37pm
8-K
5mwna
5 Aug 21
Mirati Therapeutics Reports Second Quarter 2021 Financial Results
4:34pm
8-K
cr1b6w36y3ot0huxq
2 Jul 21
Other Events
4:04pm